We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Revvity Logo

Revvity

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity serves customers across pharmaceutical and biotech, diagnostic labs, academia and governments.

Latest Revvity Content

hand holding lightbulb on yellow background
How To Guide

Top Tips for Enhancing Single-Cell Sequencing

This guide explores the nuances of these challenges and presents promising strategies designed to overcome them, enabling researchers to access the full spectrum of cellular diversity and function in health and disease.
TMI10
Video
Advertisement

Drug Discovery and CROs: A Journey Beyond Spreadsheets and Email

In this episode, we speak with Chris Stumpf, Director, Drug Discovery Informatics Solutions at Revvity Signals.
Liver Fibrosis
App Note / Case Study

A Novel Approach for Non-Invasive Liver Research

This case study utilizes non-invasive ultrasound imaging to visualize and quantify liver echogenicity and stiffness, providing critical insights into both disease progression and the efficacy of therapeutic interventions in mouse models.
Someone holding a new born baby.
Product News

Early Check Newborn Screening Study Taps Revvity To Provide Genome Sequencing

The North Carolina-based study will continue to test enrolled newborns for hundreds of childhood-onset rare genetic conditions.
Cells.
Product News

Revvity Unveils a New Era of Automated Tuberculosis Testing

New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.
A scientist in a lab.
Product News

Revvity Unveils a New Era of Automated Tuberculosis Testing

New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.
A newborn baby's feet.
Product News

Early Check Newborn Screening Study Taps Revvity To Provide Genome Sequencing

RTI International has announced that Early Check, a groundbreaking research study that provides free voluntary health tests for newborns up to four weeks old in North Carolina, has chosen Revvity, Inc. to conduct genome sequencing for the study starting in May.
A lab worker using an ipad.
Product News

Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners

New CRO system-level expansion elevates data stewardship and enables organizations to gain more insight with less oversight.
Double helix structure of DNA.
Product News

Revvity Introduces New Workflow to Accelerate Newborn Sequencing Research

Designed to build the foundation for diagnosing rare diseases in the future. Ability to perform workflow analysis through in-house global laboratory network.
A scientist holding a vial.
Product News

Revvity Signals Software Introduces Signals ChemDraw

Next-generation suite enhances research productivity and innovation across chemical, pharmaceutical, and biotechnology industries and academia.
Advertisement